Enrolling by invitationNCT06860828
The DIAGNOSE CTE Research Project-II
Studying Dementia pugilistica
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Boston University
- Principal Investigator
- Michael Alosco, PhDBoston University Alzheimer's Disease and CTE Center
- Enrollment
- 350 enrolled
- Eligibility
- 50 years · MALE
- Timeline
- 2025 – 2029
Study locations (5)
- Banner Alzheimer's Institute (BAI) and Mayo Clinic Arizona, Phoenix, Arizona, United States
- University of California, San Francisco (UCSF) Alzheimer Disease Research Center (ADRC), San Francisco, California, United States
- 1Florida ADRC, University of Florida, Gainesville, Florida, United States
- Boston University Alzheimer Disease Research Center (ADRC), Boston, Massachusetts, United States
- South Texas ADRC University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS) · University of California, San Francisco (UCSF) Alzheimer Disease Research Center (ADRC) · 1Florida ADRC, University of Florida · University of Texas Health Science Center at San Antonio (South Texas) ADRC · Laboratory of Neuro Imaging (LONI) at University of Southern California (USC) · Concussion Legacy Foundation (CLF) · Banner Alzheimer's Institute
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06860828 on ClinicalTrials.govOther trials for Dementia pugilistica
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNCT07521384Real World Outcomes of Intranasal MuSE Exosomes and Stem Cells in Neurological Regenerative TherapyHealing Hope International
- RECRUITINGPHASE3NCT06254469Visualizing Brain Proteinopathies Using [F-18]Flornaptitril-PET in the Prediction of Clinical Progression of Mild Cognitive Impairment With Either Suspected Chronic Traumatic Encephalopathy or Alzheimer's DiseaseCereMark Pharma, LLC
- RECRUITINGNCT07302503Pilot Study Evaluating brainQuant's Ability to Detect Alterations in White Matter in Diffusion MRI, Indicative of Post-traumatic LesionsUniversity Hospital, Strasbourg, France
- RECRUITINGNCT04124029Contributions of mTBI to Neurodegeneration Due to Chronic Traumatic Encephalopathy (CTE) and Alzheimer's Disease (AD)VA Office of Research and Development
- RECRUITINGNCT03218332Post-Concussion Syndrome in Professional Athletes: A Multidisciplinary StudyUniversity Health Network, Toronto